Stock Market News

Novo licenses Chinese biotech's obesity drug candidate for up to $2 billion

Mar 24, 2025 - 13:37
 0
Novo licenses Chinese biotech's obesity drug candidate for up to $2 billion
Read More

Tags:

Previous Article

UBS Group AG hires tech dealmaker Carmine Visconti for senior role - Bloomberg

Next Article

Jefferies raises FedEx rating on incremental cost cuts

Related Posts

European shares drop as Trump's fresh tariffs take effect

European shares drop as Trump's fresh tariffs take effect

Mar 4, 2025  0

US Supreme Court leans toward gun companies' bid to avoid Mexico's lawsuit

US Supreme Court leans toward gun companies' bid to avo...

Mar 4, 2025  0

Cisco lifts FY guidance after Q2 results beat expectations

Feb 12, 2025  0